Filter
1160
Text search:
human
pharmaceutical
products
Featured
116
313
Language
Document type
522
260
194
72
68
15
14
8
4
2
1
Countries
56
52
37
36
27
26
26
25
24
22
19
18
18
17
15
15
14
14
13
12
12
11
11
11
11
9
8
8
7
6
6
6
6
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
476
82
63
56
32
23
10
1
Toolboxes
154
129
71
53
46
39
35
26
23
22
22
19
19
19
17
17
13
8
8
6
5
4
3
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was
...
WHO Secretariat Information paper July 2016
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Prices people pay for medicines.
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor
...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei
...
Health Systems in Transition. Vol. 5 No.3 2015
